Well, I am over my disappointment.
Pending JV approval, they are going to test the Kockatea and then test the Carynginia/IRCM & HCSS at the same time.
Furthermore, the IRCM has TOC of 7-8%. HUGE!
"The lower part of the IRCM appears to be similar to the HCSS interval – if this is correct, resources could be significantly higher than expected from this combined interval"
HUGE!
So they are starting the Kockatea by the end of this month, results by the end of November and then testing the rest throughout December/Early Jan.
Resource estimate by end of Jan/early Feb.
- Forums
- ASX - By Stock
- NWE
- quarterly is out!!
quarterly is out!!, page-149
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NWE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online